PCA
IDXX icon

Pallas Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Pallas Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Sell
1,806
-252
-12% -$162K 0.04% 328
2025
Q4 		$1.39M Sell
2,058
-203
-9% -$138K 0.05% 289
2025
Q3 		$1.44M Sell
2,261
-73
-3% -$44.3K 0.05% 263
2025
Q2 		$1.25M Buy
2,334
+1,221
+110% +$584K 0.05% 281
2025
Q1 		$467K Buy
+1,113
New +$483K 0.02% 486

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pallas Capital Advisors's IDXX Position: Q1 2026 in Review

Pallas Capital Advisors reduced its Idexx Laboratories (IDXX) stake by 12% in Q1 2026, selling an estimated $162K and leaving 1,806 shares worth $1.01M. The position accounts for 0.04% of the portfolio, ranked #328.

Pallas Capital Advisors first reported a position in IDXX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.44M in Q3 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Pallas Capital Advisors held 1,806 shares of Idexx Laboratories worth $1.01M as of Q1 2026.
  • Pallas Capital Advisors sold 252 Idexx Laboratories shares in Q1 2026, an estimated $162K.
  • Idexx Laboratories made up 0.04% of Pallas Capital Advisors's portfolio in Q1 2026, its #328 holding.
  • Pallas Capital Advisors first reported a position in Idexx Laboratories in Q1 2025 and has held it in 5 quarters since.
  • Pallas Capital Advisors's Idexx Laboratories position peaked at $1.44M in Q3 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.